MARKET

PRPH

PRPH

Prophase Labs Inc
NASDAQ
4.560
+0.090
+2.01%
Closed 16:00 03/01 EST
OPEN
4.520
PREV CLOSE
4.470
HIGH
4.570
LOW
4.373
VOLUME
50.26K
TURNOVER
0
52 WEEK HIGH
9.94
52 WEEK LOW
4.050
MARKET CAP
82.29M
P/E (TTM)
-7.3525
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PRPH last week (0219-0223)?
Weekly Report · 4d ago
HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $11 Price Target
Benzinga · 02/21 18:20
Analysts Offer Insights on Healthcare Companies: Prophase Labs (PRPH) and Crispr Therapeutics AG (CRSP)
TipRanks · 02/21 17:00
Weekly Report: what happened at PRPH last week (0212-0216)?
Weekly Report · 02/19 09:57
Buy Rating for Prophase Labs on Strong Clinical Trial Results and Manufacturing Expansion
TipRanks · 02/15 11:27
Weekly Report: what happened at PRPH last week (0205-0209)?
Weekly Report · 02/12 09:52
Weekly Report: what happened at PRPH last week (0129-0202)?
Weekly Report · 02/05 09:56
Weekly Report: what happened at PRPH last week (0122-0126)?
Weekly Report · 01/29 09:52
More
About PRPH
ProPhase Labs, Inc. is a diagnostics, genomics and biotech company. The Company leverages its Clinical Laboratory Improvement Amendments (CLIA) lab services to provide whole genome sequencing and research direct to consumers and build a genomics database to be used for further research. It provides traditional CLIA molecular laboratory services, including coronavirus disease (COVID-19) testing. It also operates Pharmaloz, a contract manufacturing subsidiary, which offers the TK Supplements line of dietary supplements, which are distributed in food, drug, and mass stores. The Company's wholly owned subsidiary ProPhase Diagnostics, Inc, offers a broad array of clinical diagnostic and testing services at its CLIA-certified laboratories including polymerase chain reaction (PCR) testing for SARS-CoV-2 (COVID-19) and Influenza A and Influenza B. It also owns the exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening test.

Webull offers ProPhase Labs Inc stock information, including NASDAQ: PRPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRPH stock methods without spending real money on the virtual paper trading platform.